Bioteknik: "With or without any doubts about the BOD, ...."
I fully agree that CYP's share-price should be going 'skywards'. However, an either good or alternatively a somewhat doubtful BOD will have in fact quite a CRUCIAL effect upon the kind of re-rating that a stock makes. JIMHO, of course.
wasa
Ann: Cynata GvHD Trial Meets all Safety & Efficacy Endpoints, page-36
Add CYP (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
25.0¢ |
Change
0.015(6.38%) |
Mkt cap ! $45.16M | |||
| Open | High | Low | Value | Volume |
| 25.0¢ | 28.0¢ | 24.5¢ | $103.8K | 408.9K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 4 | 35587 | 25.0¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 28.0¢ | 7013 | 2 |
View Market Depth
| Last trade - 16.10pm 02/10/2024 (20 minute delay) ? |
| CYP (ASX) Chart |